The Actinium-225 demand ecosystem spans a diverse set of buyers, from commercial radiopharmaceutical manufacturers securing supply for late-stage pipelines to academic medical centers running early-stage investigator-led trials. Each buyer type sources Ac-225 differently, on different timelines, at different volumes, and for different purposes, and understanding that structure is essential for any
View Detail